Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein

被引:46
作者
Farrow, Mary F. [1 ,2 ]
Rubin, Eric J. [1 ,2 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
关键词
D O I
10.1128/JB.01046-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The lprG-Rv1410c operon is critical for the survival of Mycobacterium tuberculosis during infection, but very little is known about the functions of its proteins. LprG is a lipoprotein, and Rv1410c encodes the major facilitator superfamily small molecule transporter P55. P55 likely exports small molecules outside of the bacterial cell, but the function of LprG is unclear. A deletion of the homologous operon in Mycobacterium smegmatis is more susceptible to ethidium bromide, and drug resistance is restored by the intact operon from M. tuberculosis. The multidrug resistance pump inhibitor reserpine inhibits resistance to ethidium bromide in both wild-type M. smegmatis and the complemented mutant, suggesting that P55-mediated transport is responsible for drug resistance and that ethidium bromide is a novel substrate for P55. In addition to hypersensitivity to ethidium bromide, cells that lack the lprG-Rv1410c operon display abnormal colony morphology and are defective for sliding motility, properties that suggest an alteration of cell wall composition. Strikingly, both ethidium bromide transport and normal cell surface properties require functional P55 and LprG, as neither alone is sufficient to restore function to the deletion mutant. Thus, P55 requires the cell surface lipoprotein for normal function.
引用
收藏
页码:1783 / 1791
页数:9
相关论文
共 15 条
[1]   A novel 27 kDa lipoprotein antigen from Mycobacterium bovis [J].
Bigi, F ;
Espitia, C ;
Alito, A ;
Zumarraga, M ;
Romano, MI ;
Cravero, S ;
Cataldi, A .
MICROBIOLOGY-SGM, 1997, 143 :3599-3605
[2]   The gene encoding P27 lipoprotein and a putative antibiotic-resistance gene form an operon in Mycobacterium tuberculosis and Mycobacterium bovis [J].
Bigi, F ;
Alito, A ;
Romano, MI ;
Zumarraga, M ;
Caimi, K ;
Cataldi, A .
MICROBIOLOGY-UK, 2000, 146 :1011-1018
[3]   The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis [J].
Bigi, F ;
Gioffré, A ;
Klepp, L ;
Santangelo, MD ;
Alito, A ;
Caimi, K ;
Meikle, V ;
Zumárraga, M ;
Taboga, O ;
Romano, MI ;
Cataldi, A .
MICROBES AND INFECTION, 2004, 6 (02) :182-187
[4]   THE ENVELOPE OF MYCOBACTERIA [J].
BRENNAN, PJ ;
NIKAIDO, H .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :29-63
[5]   Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis [J].
Camacho, LR ;
Ensergueix, D ;
Perez, E ;
Gicquel, B ;
Guilhot, C .
MOLECULAR MICROBIOLOGY, 1999, 34 (02) :257-267
[6]   Complex lipid determine tissue specific replication of Mycobacterium tuberculosis in mice [J].
Cox, JS ;
Chen, B ;
McNeil, M ;
Jacobs, WR .
NATURE, 1999, 402 (6757) :79-83
[7]   Mycobacterium tuberculosis LprG (Rv1411c):: A novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing [J].
Gehring, AJ ;
Dobos, KM ;
Belisle, OT ;
Harding, CV ;
Boom, WH .
JOURNAL OF IMMUNOLOGY, 2004, 173 (04) :2660-2668
[8]  
Martínez A, 1999, J BACTERIOL, V181, P7331
[9]   Synthesis of an unusual polar glycopeptidolipid in glucose-limited culture of Mycobacterium smegmatis [J].
Ojha, AK ;
Varma, S ;
Chatterji, D .
MICROBIOLOGY-SGM, 2002, 148 :3039-3048
[10]  
Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1